中国医疗保健-从生存到发展 - 深度剖析中国小盘生物技术企业；首次覆盖 Abbisko 并给予买入评级-China Healthcare_ Biotechnology_ From Survive to Thrive - Deep-dive on China's small-cap biotech; initiate on Abbisko at Buy
2025-10-27 00:52
26 October 2025 | 5:51PM HKT Equity Research CHINA HEALTHCARE: BIOTECHNOLOGY From Survive to Thrive - Deep-dive on China's small-cap biotech; initiate on Abbisko at Buy An inflection point for small-cap China biotech; Initiate on Abbisko: As China's innovative drug assets continue gaining global recognition, it has come to an inflection point particularly for small-cap China biotech companies that have been through difficulties in the down cycle since 2021, and are now taking steps from survive to thrive. W ...